Valproic acid prodrug affects selective markers, augments doxorubicin anticancer activity and attenuates its toxicity in a murine model of aggressive breast cancer
Nataly Tarasenko, Harel Josef Wilner, Abraham Nudelman, Gania Kessler-Icekson, Ada Rephaeli
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Valproic acid prodrug affects selective markers, augments doxorubicin anticancer activity and attenuates its toxicity in a murine model of aggressive breast cancer'. Together they form a unique fingerprint.